CLINICAL_TRIALS
trial_result
· 2014-05-30
Clinical Trial Update: Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients [Phase 3]
Summary
A Phase 3 extension study assessed long-term efficacy and safety of everolimus in liver transplant recipients; completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Liver Transplant Recipient | Phase 3 | Status: COMPLETED | Results posted: 2014-05-30